Patents by Inventor Robert A. Porter
Robert A. Porter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11921289Abstract: A personal display device for displaying virtual images to a wearer. The personal display device includes a frame having a right temple section, a left temple section, a right rear section, a left rear section, a right eye see-through section, and a left eye see-through section; a projection display device connected to the frame for projecting an image to the wearer; at least one waveguide stack module connected to the frame for propagating image-bearing light beams along a length of the at least one waveguide stack module, the at least one waveguide stack module being configured to receive the image from the projection display device and detected touch motions of the wearer sensed by the touchpad including sensing directions of the touch motions of the wearer.Type: GrantFiled: December 18, 2018Date of Patent: March 5, 2024Assignee: Vuzix CorporationInventors: Paul Travers, Tyler Porter, Robert Schultz, Gregory Moens, Connor Hack, Adalberto Perez Reyes, Kevin Lloyd, Marc J. Krolczyk, Michael J. Telek, Paul A. Boris, Robert W. Gray, Alexander Kelly
-
Publication number: 20230337947Abstract: Various examples are directed to a glucose sensor comprising a working electrode to support an oxidation reaction and a reference electrode to support a redox reaction. The reference electrode may comprise silver and silver chloride. The Glucose sensor may also comprise an anti-mineralization agent positioned at the reference electrode to reduce formation of calcium carbonate at the reference electrode.Type: ApplicationFiled: March 24, 2023Publication date: October 26, 2023Inventors: Sebastian Bohm, Wenjie Lan, Thomas Robert Porter, Daiting Rong, Jason Halac
-
Publication number: 20230267778Abstract: A system and method for preventing vehicle collisions is provided. The system includes a transmitter system on the first vehicle, a machine mounted locator on the second vehicle, means for determining coordinates of the machine mounted locator relative to the transmitter system; means for defining a safety zone around the first vehicle; and warning means for generating a signal when the machine mounted locator enters the safety zone surrounding the first vehicle. The method includes the steps of: generating and transmitting an encoded signal around the first vehicle; receiving the encoded signal at a machine mounted locator on the second vehicle; processing the encoded signal; transmitting a locator radio frequency signal from the machine mounted locator in response to the encoded signal; receiving the locator radio frequency signal at the transmitter system; and performing an algorithm to determine coordinates of the machine mounted locator relative to the transmitter system.Type: ApplicationFiled: April 28, 2023Publication date: August 24, 2023Applicant: MATRIX DESIGN GROUP LLCInventors: Ben Lemond, Robert Porter, Jeff Polk, Kenton Wilson
-
Patent number: 11709865Abstract: A system that provides for the accessing and playing of media files having differing associated rights such as non-DRM media files, purchased and downloaded media files, subscription download files such as tethered downloads, and subscription streamed DRM files. The system also provides a method and user interface for sharing a media collection among computing devices in communication via a network. The system allows access and playback, from each computing device on a network, of all media files in a media collection, regardless of their associated rights.Type: GrantFiled: January 2, 2020Date of Patent: July 25, 2023Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Ryan Eric King, David E. Brown, Robert Porter, Adam Korman, Manish Upendran, Kathleen Wilson
-
Publication number: 20230194541Abstract: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Accordingly, these compounds can be used as modulators of TNF. Anew assay for identifying compounds with this mechanism of action is also disclosed.Type: ApplicationFiled: August 30, 2022Publication date: June 22, 2023Inventors: James Philip O'CONNELL, John Robert PORTER, Alastair LAWSON, Boris KROEPLIEN, Stephen Edward RAPECKI, Timothy John NORMAN, Graham John WARRELLOW
-
Publication number: 20230181813Abstract: The wound treatment apparatus combines an internal negative pressure (vacuum) pump and an internal positive pressure (compressor) pump connectable to an external oxygen supply for providing both negative pressure wound therapy and hyperbaric oxygen wound therapy to a wound site. The apparatus also includes a user interface operatively connected to an electronic controller that monitors and actuates the vacuum and compressor pumps. The user interface and controller enables the apparatus to provide multiple modes of operation and the ability to selectively change between negative pressure therapy operational modes and hyperbaric oxygen operational modes.Type: ApplicationFiled: July 13, 2022Publication date: June 15, 2023Inventors: Billy Wall, Stephen Galbraith, Robert Porter
-
Patent number: 11674967Abstract: A new, stable trimeric TNF? structure is disclosed with distorted symmetry which can bind to the TNFR1 receptor to attenuate signalling therefrom, which can be used in the treatment and/or prevention of diseases associated with the soluble TNF?/TNFR1 interaction. Membrane-bound TNF? is not affected in its ability to signal through TNFR2, and thus the new structure of TNF? may be used in therapies which do not significantly raise the risk of infection or malignancy.Type: GrantFiled: September 4, 2020Date of Patent: June 13, 2023Assignee: UCB BIOPHARMA SRLInventors: James Philip O'Connell, John Robert Porter, Alastair Lawson, Boris Kroeplien, Stephen Edward Rapecki, Timothy John Norman, Graham John Warrellow, Tracy Lynn Arakaki, Alex Buntin Burgin, William Ross Pitt, Mark Daniel Calmiano, David Andreas Schubert, Daniel John Lightwood, Rebecca Jayne Munro
-
Patent number: 11638543Abstract: Various examples are directed to a glucose sensor comprising a working electrode to support an oxidation reaction and a reference electrode to support a redox reaction. The reference electrode may comprise silver and silver chloride. The Glucose sensor may also comprise an anti-mineralization agent positioned at the reference electrode to reduce formation of calcium carbonate at the reference electrode.Type: GrantFiled: July 15, 2020Date of Patent: May 2, 2023Assignee: Dexcom, Inc.Inventors: Sebastian Bohm, Wenjie Lan, Thomas Robert Porter, Daiting Rong, Jason Halac
-
Patent number: 11496153Abstract: Described herein is a system and method for coded streaming data to facilitate recovery from failed or slow processor(s). A batch of processing stream data can be partitioned into a plurality of data chunks. Parity chunk(s) for the plurality of data chunks. The plurality of data chunks and the parity chunk(s) can be provided to processors for processing. Processed data of at least some (e.g., one or more) of the plurality of data chunks, and, processed data of parity chunk(s) are received. When it is determined that processed data for a pre-defined quantity of data chunks has not been received by a pre-defined period of time, the processed data for particular data chunk(s) of particular processor(s) from which processed data has not been received are determined based, at least in part, upon the received processed parity chunk(s) and the received processed data chunk(s).Type: GrantFiled: April 5, 2021Date of Patent: November 8, 2022Assignee: Microsoft Technology Licensing, LLCInventors: Todd Robert Porter, Xin Tian, Alexander Alperovich
-
Patent number: 11448655Abstract: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Accordingly, these compounds can be used as modulators of TNF. A new assay for identifying compounds with this mechanism of action is also disclosed.Type: GrantFiled: May 26, 2020Date of Patent: September 20, 2022Assignee: UCB BIOPHARMA SRLInventors: James Philip O'Connell, John Robert Porter, Alastair Lawson, Boris Kroeplien, Stephen Edward Rapecki, Timothy John Norman, Graham John Warrellow
-
Patent number: 11406749Abstract: The wound treatment apparatus combines an internal negative pressure (vacuum) pump and an internal positive pressure (compressor) pump connectable to an external oxygen supply for providing both negative pressure wound therapy and hyperbaric oxygen wound therapy to a wound site. The apparatus also includes a user interface operatively connected to an electronic controller that monitors and actuates the vacuum and compressor pumps. The user interface and controller enables the apparatus to provide multiple modes of operation and the ability to selectively change between negative pressure therapy operational modes and hyperbaric oxygen operational modes.Type: GrantFiled: October 9, 2018Date of Patent: August 9, 2022Inventors: Billy Wall, Stephen Galbraith, Robert Porter
-
Publication number: 20220094169Abstract: Renewable electrical energy is provided with aspects and circuitry that can harvest maximum power from an alternative electrical energy source (1) such as a string of solar panels (11) for a power grid (10). Aspects include: i) controlling electrical power creation from photovoltaic DC-AC inverter (5), ii) operating photovoltaic DC-AC inverter (5) at maximal efficiency even when MPP would not be, iii) protecting DC-AC inverter (5) so input can vary over a range of insolation and temperature, and iv) providing dynamically reactive capability to react and assure operation, to permit differing components, to achieve code compliant dynamically reactive photovoltaic power control circuitry (41). With previously explained converters, inverter control circuitry (38) or photovoltaic power converter functionality control circuitry (8) configured as inverter sweet spot converter control circuitry (46) can achieve extraordinary efficiencies with substantially power isomorphic photovoltaic capability at 99.Type: ApplicationFiled: November 29, 2021Publication date: March 24, 2022Inventors: Robert Porter, Anatoli Ledenev
-
Publication number: 20220074947Abstract: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.Type: ApplicationFiled: May 19, 2021Publication date: March 10, 2022Inventors: James Philip O'CONNELL, John Robert PORTER, Alastair LAWSON, Tracy Lynn ARAKAKI, Daniel John LIGHTWOOD, Rebecca Jayne MUNRO
-
Publication number: 20220025033Abstract: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.Type: ApplicationFiled: October 13, 2021Publication date: January 27, 2022Inventors: Alastair David Griffiths LAWSON, Daniel John LIGHTWOOD, Rebecca Jayne MUNRO, James Philip O'CONNELL, John Robert PORTER
-
Patent number: 11228182Abstract: Renewable electrical energy is provided with aspects and circuitry that can harvest maximum power from an alternative electrical energy source (1) such as a string of solar panels (11) for a power grid (10). Aspects include: i) controlling electrical power creation from photovoltaic DC-AC inverter (5), ii) operating photovoltaic DC-AC inverter (5) at maximal efficiency even when MPP would not be, iii) protecting DC-AC inverter (5) so input can vary over a range of insolation and temperature, and iv) providing dynamically reactive capability to react and assure operation, to permit differing components, to achieve code compliant dynamically reactive photovoltaic power control circuitry (41). With previously explained converters, inverter control circuitry (38) or photovoltaic power converter functionality control circuitry (8) configured as inverter sweet spot converter control circuitry (46) can achieve extraordinary efficiencies with substantially power isomorphic photovoltaic capability at 99.Type: GrantFiled: June 12, 2019Date of Patent: January 18, 2022Assignee: Ampt, LLCInventors: Robert Porter, Anatoli Ledenev
-
Patent number: 11174311Abstract: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.Type: GrantFiled: December 13, 2017Date of Patent: November 16, 2021Assignees: UCB BIOPHARMA SRL, SANOFIInventors: Alastair David Griffiths Lawson, Daniel John Lightwood, Rebecca Jayne Munro, James Philip O'Connell, John Robert Porter
-
Patent number: 11148987Abstract: A method of reducing the salt content of a neutralized aralkyl hydroperoxide cleavage mass stream comprising passing the neutralized stream into a vessel, the vessel having an inlet, two outlets, an aqueous layer and a hydrocarbon layer wherein the neutralized stream enters the vessel through a first inlet and a hydrocarbon stream exits the vessel through a first outlet that is in fluid communication with the hydrocarbon layer.Type: GrantFiled: August 22, 2018Date of Patent: October 19, 2021Assignee: SHELL OIL COMPANYInventors: Garry Morgan McCauley, Jamie Jerrick Juliette, David Randall Faske, Thomas Robert Porter
-
Publication number: 20210308361Abstract: The wound treatment apparatus combines an internal negative pressure (vacuum) pump and an internal positive pressure (compressor) pump connectable to an external oxygen supply for providing both negative pressure wound therapy and hyperbaric oxygen wound therapy to a wound site. The apparatus also includes a user interface operatively connected to an electronic controller that monitors and actuates the vacuum and compressor pumps. The user interface and controller enables the apparatus to provide multiple modes of operation and the ability to selectively change between negative pressure therapy operational modes and hyperbaric oxygen operational modes.Type: ApplicationFiled: October 9, 2018Publication date: October 7, 2021Inventors: Billy Wall, Stephen Galbraith, Robert Porter
-
Publication number: 20210306001Abstract: Described herein is a system and method for coded streaming data to facilitate recovery from failed or slow processor(s). A batch of processing stream data can be partitioned into a plurality of data chunks. Parity chunk(s) for the plurality of data chunks. The plurality of data chunks and the parity chunk(s) can be provided to processors for processing. Processed data of at least some (e.g., one or more) of the plurality of data chunks, and, processed data of parity chunk(s) are received. When it is determined that processed data for a pre-defined quantity of data chunks has not been received by a pre-defined period of time, the processed data for particular data chunk(s) of particular processor(s) from which processed data has not been received are determined based, at least in part, upon the received processed parity chunk(s) and the received processed data chunk(s).Type: ApplicationFiled: April 5, 2021Publication date: September 30, 2021Applicant: Microsoft Technology Licensing, LLCInventors: Todd Robert PORTER, Xin TIAN, Alexander ALPEROVICH
-
Patent number: 11022614Abstract: It has been demonstrated that certain compounds bind to TNF and stabilise a conformation of trimeric TNF that binds to the TNF receptor. Antibodies which selectively bind to complexes of such compounds with TNF superfamily members are disclosed. These antibodies may be used to detect further compounds with the same activity, and as target engagement biomarker.Type: GrantFiled: October 22, 2015Date of Patent: June 1, 2021Assignee: UCB Biopharma SRLInventors: James Philip O'Connell, John Robert Porter, Alastair Lawson, Tracy Lynn Arakaki, Daniel John Lightwood, Rebecca Jayne Munro